Wilson Sonsini Goodrich & Rosati represented ReCode Therapeutics in the transaction. ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Mirvie on the deal. Mirvie, a pioneer in predicting unexpected pregnancy complications, announced it has raised $60 million in a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Apexigen on the deal. Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Synthekine on the deal. Synthekine Inc., an engineered cytokine therapeutics company, announced that it has entered into a worldwide research...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Applied Molecular Transport on the deal. Applied Molecular Transport (AMT), a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to...
You must be a Standard 1 Year member to access this content.
